Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Global Longlife Hospital and Research Limited is a Gujarat-based multi-specialty tertiary care hospital with 110 beds, providing comprehensive medical and surgical care.
Founded in 2012 and opening by 2015-16, Global Longlife Hospital was initially a private firm and became public in 2021, reflecting its growth strategy and public investment approach.
The hospital employs 11 full-time consultants and leverages additional expertise from over 30 experienced doctors, ensuring a wide range of healthcare services.
The company raised Rs. 49 Cr through an IPO in April 2022, indicating strong investor confidence and plans for future expansion.
Healthcare Services
Hospital
13 Cr
Low Risk
0.0
63.3
—
0.5
26.73
9.00
Sales CAGR
Profit CAGR
ROE
ROCE
Global Longlife Hospital and Research Ltd (GLHRL) is currently trading at 12.21 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Global Longlife Hospital and Research Limited is a Gujarat-based multi-specialty tertiary care hospital with 110 beds, providing comprehensive medical and surgical care. Founded in 2012 and opening by 2015-16, Global Longlife Hospital was initially a private firm and became public in 2021, reflecting its growth strategy and public investment approach. The hospital employs 11 full-time consultants and leverages additional expertise from over 30 experienced doctors, ensuring a wide range of healthcare services. The company raised Rs. 49 Cr through an IPO in April 2022, indicating strong investor confidence and plans for future expansion.
Over the past 52 weeks, Global Longlife Hospital and Research Ltd has traded between a low of ₹9.00 and a high of ₹26.73. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Global Longlife Hospital and Research Ltd has a market capitalization of approximately 12.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Global Longlife Hospital and Research Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 12.81 Cr, Global Longlife Hospital and Research Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Global Longlife Hospital and Research Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Global Longlife Hospital and Research Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
6
Neutral
4
Bullish
4
Bearish
17
Neutral
8
Bullish
21
Bearish
11
Neutral
4
Bullish
17
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
42.20 | 57 Cr | 13.66 | 1.35 | 0.00 | 9.91 | 12.37 | 7.93 | ||
17.75 | 40 Cr | 55.47 | 0.79 | 0.00 | 1.40 | 3.26 | 0.93 | ||
38.99 | 27 Cr | — | 2.08 | 0.00 | -4.87 | -5.70 | -4.13 | ||
46.02 | 22 Cr | — | 0.00 | 0.00 | 219.47 | -11.64 | -10.16 | ||
12.20 | 13 Cr | — | 0.54 | 0.00 | -7.24 | -4.16 | -7.24 | ||
13.11 | 8 Cr | 93.64 | 0.84 | 0.00 | 0.92 | 2.64 | 0.74 | ||
| Median: 6 Co. | — | 28.37 | 24 Cr | 55.47 | 0.81 | 0.00 | 1.16 | -0.76 | -1.69 |
Regulatory/Compliance Filing
Global Longlife Hospital and Research Ltd submitted certificate under Regulation 74(5) from RTA Bigshare Services Pvt. Ltd. for the quarter ended June 30, 2026 to BSE for records.
Regulatory/Compliance Filing
Global Longlife Hospital and Research Ltd submitted the certificate under Regulation 74(5) for the quarter ended 30-06-2026 from Bigshare Services (RTA) confirming dematerialisation processing and records.
